Literature DB >> 21289011

Transforming growth factor-β and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes.

Yung-Hsin Yeh1, Chi-Tai Kuo, Ting-Hsiang Chan, Gwo-Jyh Chang, Xiao-Yan Qi, FengChun Tsai, Stanley Nattel, Wei-Jan Chen.   

Abstract

AIMS: Atrial fibrillation (AF), a common tachyarrhythmia in clinical practice, is associated with increased oxidative stress. Structural remodelling in atrial myocytes, including myofibril degradation, is an important characteristic of AF. However, the mechanism underlying AF-induced cellular structural remodelling remains unclear. The aim of this study was to investigate the role of oxidative stress and related factors in tachycardia-induced atrial structural remodelling. METHODS AND
RESULTS: Cultured atrial-derived myocytes (HL-1 cell line) were subjected to electrical stimulation. Immunofluorescence and immunoblotting were used to evaluate oxidative stress, myofibril degradation, and transforming growth factor-β (TGF-β) expression. Tachypacing in HL-1 cells induced TGF-β expression, pronounced oxidative stress including up-regulation of NADPH oxidases (Nox2/4), and myofibril degradation. Oxidative stress scavenger, NADPH oxidase inhibitors, and small-interfering RNAs for Nox2/4 blocked tachypacing-induced myofibril degradation, suggesting that Nox-derived oxidative stress may lead to tachycardia-induced myofibril degradation. Blockade of TGF-β signalling by neutralizing TGF-β antibodies attenuated myofibril loss in response to tachypacing, implicating autocrine and/or paracrine roles for TGF-β in such effects. Tachypacing also induced the activation of p-Smad3 (an effective mediator of TGF-β) and small-interfering RNAs for Nox2/4 attenuated its activation, supporting a crosstalk between both signalling pathways. Furthermore, TGF-β expression, oxidative stress, and myofibril loss were greater in the atria of patients with AF than those with sinus rhythm.
CONCLUSIONS: Rapid activation in atrial myocytes promotes myofibril degradation through autocrine/paracrine TGF-β signalling and increased oxidative stress. These findings provide an important mechanistic insight into AF-related structural remodelling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289011     DOI: 10.1093/cvr/cvr041

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  25 in total

1.  Oxidative stress-associated senescence in dermal papilla cells of men with androgenetic alopecia.

Authors:  James H Upton; Rosalind F Hannen; Adiam W Bahta; Nilofer Farjo; Bessam Farjo; Michael P Philpott
Journal:  J Invest Dermatol       Date:  2015-02-03       Impact factor: 8.551

Review 2.  Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation.

Authors:  Christopher E Woods; Jeffrey Olgin
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

Review 3.  Perspectives and challenges of antioxidant therapy for atrial fibrillation.

Authors:  Iveta Gasparova; Peter Kubatka; Radka Opatrilova; Martin Caprnda; Slavomira Filipova; Luis Rodrigo; Leone Malan; Ioana Mozos; Miroslava Rabajdova; Vladimir Nosal; Nazarii Kobyliak; Vanda Valentova; Daniel Petrovic; Mariusz Adamek; Peter Kruzliak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-11-29       Impact factor: 3.000

4.  Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.

Authors:  Zuowen He; Xu Zhang; Chen Chen; Zheng Wen; Samantha L Hoopes; Darryl C Zeldin; Dao Wen Wang
Journal:  Cardiovasc Res       Date:  2015-01-24       Impact factor: 10.787

Review 5.  Transforming growth factor-β in myocardial disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Nat Rev Cardiol       Date:  2022-01-04       Impact factor: 32.419

Review 6.  Oxidant and Inflammatory Mechanisms and Targeted Therapy in Atrial Fibrillation: An Update.

Authors:  Alejandra Gutierrez; David R Van Wagoner
Journal:  J Cardiovasc Pharmacol       Date:  2015-12       Impact factor: 3.105

Review 7.  NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?

Authors:  Sanghamitra Sahoo; Daniel N Meijles; Patrick J Pagano
Journal:  Clin Sci (Lond)       Date:  2016-03       Impact factor: 6.124

Review 8.  Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase.

Authors:  Ji-Youn Youn; Jun Zhang; Yixuan Zhang; Houzao Chen; Depei Liu; Peipei Ping; James N Weiss; Hua Cai
Journal:  J Mol Cell Cardiol       Date:  2013-05-02       Impact factor: 5.000

9.  Constitutive Expression of a Dominant-Negative TGF-β Type II Receptor in the Posterior Left Atrium Leads to Beneficial Remodeling of Atrial Fibrillation Substrate.

Authors:  Aaron Kunamalla; Jason Ng; Vamsi Parini; Shin Yoo; Kate A McGee; Todd T Tomson; David Gordon; Edward B Thorp; Jon Lomasney; Qiang Zhang; Sanjiv Shah; Suzanne Browne; Bradley P Knight; Rod Passman; Jeffrey J Goldberger; Gary Aistrup; Rishi Arora
Journal:  Circ Res       Date:  2016-05-23       Impact factor: 17.367

Review 10.  Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

Authors:  Christopher L-H Huang
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.